abstract |
Anti-angiogenic adenovirus vectors, and therapeutic uses thereof, and more particularly, but not exclusively, clinical protocols for the treatment of solid tumors in patients with an adenovirus vector Ad5-PPE-1-3X-fas-chimera are provided. . |